Brief: IO Biotech Provides Update Following Pre-BLA Meeting with FDA
29/09/2025 12:11
Sept 29 (Reuters) - IO Biotech Inc IOBT.O: IO BIOTECH PROVIDES UPDATE FOLLOWING PRE-BLA MEETING WITH FDA IO BIOTECH INC - FDA RECOMMENDS IO BIOTECH NOT SUBMIT BLA FOR IOB-013 IO BIOTECH INC - PLANS NEW STUDY FOR CYLEMBIO IN MELANOMA IO BIOTECH INC - TO REDUCE WORKFORCE BY ABOUT 50% IO BIOTECH INC - EXPECTS $1.0 MILLION-$1.5 MILLION CHARGE IN Q3 2025 Source text: ID:nGNX7J20NH Further company coverage: IOBT.O ((Reuters.Briefs@thomsonreuters.com;))